Back to top
more

Interparfums, Inc. (IPAR)

(Delayed Data from NSDQ)

$118.32 USD

118.32
221,135

-2.28 (-1.89%)

Updated Aug 1, 2025 04:00 PM ET

After-Market: $119.16 +0.84 (0.71%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (85 out of 246)

Industry: Consumer Products - Discretionary

Zacks News

Zacks Equity Research

Zacks Industry Outlook Highlights Estee Lauder, Coty, Inter Parfums, and Helen of Troy

Estee Lauder, Coty, Inter Parfums, and Helen of Troy have been highlighted in this Industry Outlook article.

Zacks Equity Research

International Flavors (IFF) Q4 Earnings Lag Estimates, Dip Y/Y

International Flavors' (IFF) Q4 top line reflects softness in the Pharma and Nourish segments, offset by growth in the Scent, and Health & Biosciences segments.

Zacks Equity Research

Medifast (MED) Q4 Earnings Beat Estimates, Revenues Dip Y/Y

Medifast's (MED) Q4 results reflect the impacts of poor customer acquisition. However, it is showing resilience, banking on its strategic focus on medically supported weight loss, indicating potential for growth.

Zacks Equity Research

Things to Note Ahead of Inter Parfums' (IPAR) Q4 Earnings

Inter Parfums' (IPAR) fourth-quarter 2023 performance will likely reflect the adverse impact of rising advertising and promotion costs. Nevertheless, a solid brand portfolio is likely to aid growth.

Ansuiya Mohta headshot

4 Cosmetics Stocks Worth Watching on Robust Industry Trends

The Zacks Cosmetics industry companies are benefiting from a burgeoning demand for skincare and personal care products. Focus on innovations is propelling The Estee Lauder Companies (EL), COTY, Inter Parfums (IPAR) and Helen of Troy (HELE).

Zacks Equity Research

Pilgrim's Pride (PPC) Q4 Earnings Coming Up: Factors to Note

Pilgrim's Pride (PPC) witnesses strength in its Mexico and Europe operations. A focus on key customers and supply-chain improvements work well for the company.

Zacks Equity Research

Can Cheniere (LNG) Pull Off a Strong Show in Q4 Earnings?

Robust export volumes and lower costs are likely to have boosted Cheniere Energy's (LNG) profit levels in the fourth quarter.

Zacks Equity Research

Itron (ITRI) to Post Q4 Earnings: Here's What You Should Know

Itron's (ITRI) fourth-quarter performance is likely to have benefited from continued momentum across all business segments.

Zacks Equity Research

Factors to Note Ahead of Coterra Energy's (CTRA) Q4 Earnings

Coterra Energy (CTRA) beat the Zacks Consensus Estimate for earnings in each of the last four quarters, resulting in an earnings surprise of 111.8%, on average.

Zacks Equity Research

Inter Parfums (IPAR) Expected to Beat Earnings Estimates: Should You Buy?

Inter Parfums (IPAR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Suncor's (SU) Q4 Earnings Preview: Key Things to Consider

Suncor Energy (SU) beat the Zacks Consensus Estimate for earnings in each of the last four quarters.

Zacks Equity Research

Wolverine (WWW) Q4 Earnings Coming Up: Factors Worth Knowing

Wolverine (WWW) battles challenges in the outdoor category, soft demand in the U.S. and European wholesale businesses and weakness in the DTC channel.

Zacks Equity Research

Here's How FEMSA (FMX) is Placed Just Ahead of Q4 Earnings

FEMSA's (FMX) Q4 results are expected to reflect effective growth strategies and robust market demand, which are likely to drive growth across all units.

Zacks Equity Research

Helen of Troy (HELE) Benefits From Brand Strength & Project Pegasus

Helen of Troy (HELE) is on track with Project Pegasus, which aims to expand operating margins via improved efficiency and lower costs.

Zacks Equity Research

What's in the Cards for Keurig Dr Pepper (KDP) in Q4 Earnings?

Keurig Dr Pepper's (KDP) fourth-quarter 2023 results are likely to reflect gains from brand strength, significant pricing actions and a solid performance in its cold beverages.

Zacks Equity Research

Marathon (MRO) Q4 Earnings on Deck: Here's How It Will Fare

Lower commodity price realizations and the increase in costs are likely to have impacted the fourth-quarter earnings of Marathon Oil (MRO).

Zacks Equity Research

TreeHouse Foods (THS) Q4 Earnings Beat, Sales Decline Y/Y

TreeHouse Foods' (THS) fourth-quarter fiscal 2023 results reflect soft sales and earnings due to supply-chain hurdles at one of the broth facilities.

Zacks Equity Research

International Flavors (IFF) to Post Q4 Earnings: What's in Store?

International Flavors' (IFF) Q4 results are likely to reflect the impacts of lower volumes and escalating costs.

Zacks Equity Research

Service Corp (SCI) Hikes Dividend: What Else Should You Know?

Service Corp (SCI) announces a dividend increase, showcasing its commitment to delivering value to its shareholders.

Zacks Equity Research

Medifast (MED) Q4 Earnings Coming Up: What Should You Know?

Medifast's (MED) fourth-quarter results are likely to reflect the impacts of macroeconomic challenges like inflation, while key growth initiatives like innovation bode well.

Zacks Equity Research

Is Inter Parfums (IPAR) Stock Outpacing Its Consumer Staples Peers This Year?

Here is how Inter Parfums (IPAR) and Kerry Group PLC (KRYAY) have performed compared to their sector so far this year.

Zacks Equity Research

Dutch Bros (BROS) to Post Q4 Earnings: What's in the Cards?

Dutch Bros' (BROS) fourth-quarter 2023 top-line results are likely to reflect gains from strength in its underlying business and expansion initiatives.

Zacks Equity Research

Nu Skin (NUS) Q4 Earnings Top Estimates, Revenues Decline Y/Y

Nu Skin's (NUS) fourth-quarter 2023 results reflect the persistence of macroeconomic challenges and hurdles related to business transformation, offset by growth in some regions.

Zacks Equity Research

Nu Skin Enterprises (NUS) Surpasses Q4 Earnings and Revenue Estimates

Nu Skin (NUS) delivered earnings and revenue surprises of 27.59% and 1.94%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Molson Coors (TAP) Q4 Earnings & Sales Beat on Brand Strength

Molson Coors' (TAP) fourth-quarter 2023 results benefit from brand strength and impressive performances across both its business units.